chrX-14796910-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The NM_001410764.1(FANCB):c.2616C>T(p.Cys872=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000381 in 110,305 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., 9 hem., cov: 21)
Consequence
FANCB
NM_001410764.1 synonymous
NM_001410764.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.299
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant X-14796910-G-A is Benign according to our data. Variant chrX-14796910-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3067458.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.299 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000381 (42/110305) while in subpopulation AFR AF= 0.00135 (41/30401). AF 95% confidence interval is 0.00102. There are 0 homozygotes in gnomad4. There are 9 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 9 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FANCB | NM_001410764.1 | c.2616C>T | p.Cys872= | synonymous_variant | 12/13 | ||
FANCB | XR_001755672.2 | n.2891C>T | non_coding_transcript_exon_variant | 12/15 | |||
FANCB | XR_001755673.2 | n.6833C>T | non_coding_transcript_exon_variant | 11/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FANCB | ENST00000696353.1 | c.2616C>T | p.Cys872= | synonymous_variant | 12/13 | A2 | |||
FANCB | ENST00000696354.1 | c.*233C>T | 3_prime_UTR_variant | 11/11 | A2 | ||||
FANCB | ENST00000696352.1 | c.2616C>T | p.Cys872= | synonymous_variant, NMD_transcript_variant | 12/15 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 42AN: 110257Hom.: 0 Cov.: 21 AF XY: 0.000277 AC XY: 9AN XY: 32477
GnomAD3 genomes
AF:
AC:
42
AN:
110257
Hom.:
Cov.:
21
AF XY:
AC XY:
9
AN XY:
32477
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.000381 AC: 42AN: 110305Hom.: 0 Cov.: 21 AF XY: 0.000277 AC XY: 9AN XY: 32535
GnomAD4 genome
AF:
AC:
42
AN:
110305
Hom.:
Cov.:
21
AF XY:
AC XY:
9
AN XY:
32535
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | FANCB: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at